Effect of Varenicline on Cognitive Function in Cigarette Smokers With Schizophrenia.
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Varenicline (Primary)
- Indications Schizoaffective disorder; Schizophrenia; Smoking withdrawal
- Focus Pharmacodynamics
- 25 Aug 2016 Status changed from active, no longer recruiting to completed.
- 24 Feb 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 17 Mar 2014 Planned End Date changed from 1 Jun 2014 to 1 Dec 2014 as reported by ClinicalTrials.gov.